Related Experiment Video
Updated: Jun 17, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Oral voriconazole for invasive fungal skull base infection
M J Parsonage1, N D Stafford, P Lillie
1Department of Infectious and Tropical Diseases, Hull and East Yorkshire Hospitals NHS Trust, UK. mparsonage@btopenworld.com
Background:
Intravenous amphotericin or intravenous voriconazole, both followed by oral voriconazole, have previously been given to treat invasive aspergillosis of the skull base.
Case Report:
Exclusively oral voriconazole was used in an immunocompetent patient with biopsy-proven, invasive aspergillosis. She had a large, erosive lesion extending from the central skull base to the right orbit and ethmoid sinus, and displacing the right internal carotid artery. After four months of oral treatment as an out-patient, a repeated computed tomography scan showed a fully treated infection with post-infectious changes only, and treatment was terminated. Two years later, there had been no recurrence.
Conclusion:
Substantial cost savings were made by using exclusively oral treatment, compared with the use of intravenous voriconazole or amphotericin, or a switch strategy.
Insights
This study shows that exclusively oral voriconazole can effectively treat invasive skull base aspergillosis in immunocompetent patients. This approach offers significant cost savings compared to intravenous treatments.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Invasive aspergillosis of the skull base is typically managed with intravenous antifungals like amphotericin or voriconazole.
- Previous treatment strategies involved intravenous administration followed by oral voriconazole.
Observation:
- A case of biopsy-proven, invasive aspergillosis of the skull base in an immunocompetent patient is presented.
- The infection involved the central skull base, right orbit, and ethmoid sinus, causing displacement of the right internal carotid artery.
- Treatment was administered exclusively via oral voriconazole on an outpatient basis.
Findings:
- After four months of oral voriconazole treatment, computed tomography scans confirmed complete resolution of the infection.
- The patient experienced no recurrence of aspergillosis two years post-treatment.
- Exclusively oral voriconazole treatment resulted in substantial cost savings compared to intravenous or switch strategies.
Implications:
- Exclusively oral voriconazole represents a cost-effective and viable treatment option for invasive skull base aspergillosis in select immunocompetent patients.
- This approach may reduce healthcare costs associated with prolonged intravenous antifungal therapy.
- Further research into oral-only antifungal regimens for invasive fungal infections is warranted.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Candidiasis
Fungal Phylum Basidiomycota
Fungal Group Zygomycota
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...